Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 19, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 November 2026 - 15:22

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 19, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/riximyo

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters